In somatotropinomas, both GH/GHR and PDGF/PDGFR can synergize the signal transduction that they elicit, at least in part by virtue of GH's ability to potentiate and sustain GH signaling. The gene discussed is PDGFRB; the disease is growth hormone-producing pituitary gland neoplasm.